OMC
ONC

Oasis Management Company’s BeOne Medicines Ltd ONC Stock Holding History

Oasis Management Company’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,000
Closed -$735K – 25
2019
Q3 		$735K Hold
6,000
– – 0.47% 18
2019
Q2 		$744K Hold
6,000
– – 0.94% 11
2019
Q1 		$792K Hold
6,000
– – 1.11% 6
2018
Q4 		$842K Hold
6,000
– – 1.35% 10
2018
Q3 		$1.03M Buy
+6,000
New +$1.01M 1.51% 6

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Oasis Management Company's ONC Position: Q4 2019 in Review

Oasis Management Company sold out of BeOne Medicines Ltd (ONC) in Q4 2019, closing a stake of 6,000 shares — an estimated $735K sold.

Oasis Management Company first reported a position in ONC in Q3 2018 and held it in 5 quarters. The position peaked at $1.03M in Q3 2018. 221 funds tracked by Wall St. Rank hold ONC as of Q4 2019.

  • Oasis Management Company reported no remaining BeOne Medicines Ltd position as of Q4 2019 after selling out during the quarter.
  • Oasis Management Company sold 6,000 BeOne Medicines Ltd shares in Q4 2019, an estimated $735K.
  • Oasis Management Company first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 5 quarters.
  • Oasis Management Company's BeOne Medicines Ltd position peaked at $1.03M in Q3 2018.
  • 221 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2019.

Based on Oasis Management Company's 13F filing for Q4 2019, filed 14 Feb 2020.